| Year |
Title |
Altmetric |
| 2023
|
Author Correction: Protein-based profiling of the human IgA1 clonal repertoire revealed shared clones of serum polymeric IgA1 and milk secretory IgA1 (Cellular & Molecular Immunology, (2023), 20, 3, (305-307), 10.1038/s41423-022-00965-z).
Cellular and Molecular Immunology.
20:310.
2023
|
|
| 2023
|
Protein-based profiling of the human IgA1 clonal repertoire revealed shared clones of serum polymeric IgA1 and milk secretory IgA1.
Cellular and Molecular Immunology.
20:305-307.
2023
|
|
| 2023
|
GalNAc-T14 may contribute to production of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Kidney International Reports.
2023
|
|
| 2022
|
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits.
Nature Communications.
13.
2022
|
|
| 2022
|
Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy.
iScience.
25.
2022
|
|
| 2022
|
Editorial: Structure, isotypes, targets, and post-translational modifications of immunoglobulins and their role in infection, inflammation and autoimmunity, Volume II.
Frontiers in Immunology.
13.
2022
|
|
| 2022
|
Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors
2022
|
|
| 2022
|
Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries.
Nephrology Dialysis Transplantation.
37:1629-1636.
2022
|
|
| 2022
|
Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy.
Journal of Clinical Medicine.
11.
2022
|
|
| 2022
|
Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.
Journal of Interferon and Cytokine Research.
42:301-315.
2022
|
|
| 2022
|
IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
Pediatric Nephrology.
37:719-733.
2022
|
|
| 2022
|
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses.
JCI Insight.
7.
2022
|
|
| 2021
|
Author Correction: Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation (Scientific Reports, (2020), 10, 1, (671), 10.1038/s41598-020-57510-z).
Scientific Reports.
11.
2021
|
|
| 2021
|
Iga vasculitis with nephritis in adults: Histological and clinical assessment.
Journal of Clinical Medicine.
10.
2021
|
|
| 2021
|
Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation.
Kidney Medicine.
3:1003-1013.e1.
2021
|
|
| 2021
|
IgA glycosylation and immune complex formation in IgAN
2021
|
|
| 2021
|
Pathogenesis of iga nephropathy: Current understanding and implications for development of disease-specific treatment.
Journal of Clinical Medicine.
10.
2021
|
|
| 2021
|
Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation.
Frontiers in Immunology.
12.
2021
|
|
| 2021
|
Aberrantly glycosylated IgA1 in IgA nephropathy: What we know and what we don’t know.
Journal of Clinical Medicine.
10.
2021
|
|
| 2021
|
Quantitative assessment of successive carbohydrate additions to the clustered O-glycosylation sites of IgA1 by glycosyltransferases.
Glycobiology.
31:540-556.
2021
|
|
| 2021
|
Transcription factor β-catenin plays a key role in fluid flow shear stress-mediated glomerular injury in solitary kidney.
Cells.
10.
2021
|
|
| 2021
|
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Journal of Autoimmunity.
118.
2021
|
|
| 2021
|
Immunoglobulin A Glycosylation and Its Role in Disease
2021
|
|
| 2020
|
Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
Scientific Reports.
10.
2020
|
|
| 2020
|
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies.
iScience.
23.
2020
|
|
| 2020
|
A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis
2020
|
|
| 2020
|
Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes
2020
|
|
| 2020
|
Persistent Disease Activity in Patients With Long-Standing Glomerular Disease.
Kidney International Reports.
5:860-871.
2020
|
|
| 2020
|
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy..
Kidney Diseases.
6:168-180.
2020
|
|
| 2020
|
Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.
Expert Review of Proteomics.
17:275-296.
2020
|
|
| 2020
|
Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?.
Journal of Nephrology.
33:307-316.
2020
|
|
| 2020
|
TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy.
Kidney International.
97:340-349.
2020
|
|
| 2019
|
Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
Kidney International Reports.
4:1717-1724.
2019
|
|
| 2019
|
Distinct Fcα receptor N-glycans modulate the binding affinity to immunoglobulin A (IgA) antibodies.
Journal of Biological Chemistry.
294:13995-14008.
2019
|
|
| 2019
|
Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression (PLoS One (2019) 14:2 (e0212254) DOI: 10.1371/journal.pone.0212254).
PLoS One.
14.
2019
|
|
| 2019
|
IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2.
Glycobiology.
29:543-556.
2019
|
|
| 2019
|
Glycosylation in health and disease.
Nature Reviews Nephrology.
15:346-366.
2019
|
|
| 2019
|
Health-related quality of life in glomerular disease.
Kidney International.
95:1209-1224.
2019
|
|
| 2019
|
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
American Journal of Kidney Diseases.
73:218-229.
2019
|
|
| 2019
|
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
PLoS One.
14.
2019
|
|
| 2019
|
Defining HIV-1 envelope N-glycan microdomains through site-specific heterogeneity profiles.
Journal of Virology.
93.
2019
|
|
| 2019
|
Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1.
Journal of the American Society of Nephrology.
30:2017-2026.
2019
|
|
| 2019
|
The emerging role of complement proteins as a target for therapy of IgA nephropathy.
Frontiers in Immunology.
10.
2019
|
|
| 2018
|
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.
Kidney International Reports.
3:1373-1384.
2018
|
|
| 2018
|
Secondary IgA nephropathy.
Kidney International.
94:674-681.
2018
|
|
| 2018
|
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
Seminars in Nephrology.
38:461-476.
2018
|
|
| 2018
|
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
2018
|
|
| 2018
|
Endothelial function, its relation to arterial hypertension and the possibility of its modulation.
Vnitrni lekarstvi.
64:762-770.
2018
|
|
| 2018
|
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
PLoS One.
13.
2018
|
|
| 2017
|
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
Nephrology Dialysis Transplantation.
32:2079-2089.
2017
|
|
| 2017
|
What insights can proteomics give us into IgA nephropathy (Berger’s disease)?.
Expert Review of Proteomics.
14:645-647.
2017
|
|
| 2017
|
Prognostic value of serum biomarkers of autoimmunity for recurrence of IGA nephropathy after kidney transplantation.
Journal of the American Society of Nephrology.
28:1943-1950.
2017
|
|
| 2017
|
A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction.
Journal of the American Society of Nephrology.
28:1306-1313.
2017
|
|
| 2017
|
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.
PLoS Genetics.
13.
2017
|
|
| 2017
|
An update on the treatment of IgA nephropathy.
Aktuality V Nefrologii.
23:60-62.
2017
|
|
| 2017
|
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.
Kidney International Reports.
2:1194-1207.
2017
|
|
| 2017
|
Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls.
International Journal of Nephrology.
2017.
2017
|
|
| 2016
|
IgA nephropathy - research-generated questions.
Vnitrni lekarstvi.
62:67-77.
2016
|
|
| 2016
|
IgA nephropathy enigma.
Clinical Immunology.
172:72-77.
2016
|
|
| 2016
|
Markers for the progression of IgA nephropathy.
Journal of Nephrology.
29:535-541.
2016
|
|
| 2016
|
The origin and activities of IgA1-containing immune complexes in IGA nephropathy.
Frontiers in Immunology.
7.
2016
|
|
| 2016
|
IgA nephropathy.
Nature Reviews Disease Primers.
2.
2016
|
|
| 2016
|
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?.
Disease Markers.
2016.
2016
|
|
| 2016
|
Somatic mutations modulate autoantibodies against galactose-deficient IgA1 in IgA nephropathy.
Journal of the American Society of Nephrology.
27:3278-3284.
2016
|
|
| 2016
|
Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
Disease Markers.
2016.
2016
|
|
| 2015
|
Current understanding of the role of complement in IgA nephropathy.
Journal of the American Society of Nephrology.
26:1503-1512.
2015
|
|
| 2015
|
New Insights into the Pathogenesis of IgA Nephropathy..
Kidney Diseases.
1:8-18.
2015
|
|
| 2015
|
Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy.
Journal of the American Society of Nephrology.
26:1195-1204.
2015
|
|
| 2015
|
N-Acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Nephrology Dialysis Transplantation.
30:234-238.
2015
|
|
| 2015
|
The serum very-low-density lipoprotein serves as a restriction factor against hepatitis C virus infection.
Journal of Virology.
89:6782-6791.
2015
|
|
| 2014
|
Origin of galactose-deficient immunoglobulin G in gingival crevicular fluid in periodontitis.
Journal of Periodontology.
85:1779-1785.
2014
|
|
| 2014
|
The kinetics of glomerular deposition of nephritogenic IgA.
PLoS One.
9.
2014
|
|
| 2014
|
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.
Nature Genetics.
46:1187-1196.
2014
|
|
| 2014
|
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.
Clinical and Experimental Nephrology.
18:770-777.
2014
|
|
| 2014
|
Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.
AIDS Research and Therapy.
11.
2014
|
|
| 2014
|
Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease.
Journal of Immunology Research.
2014.
2014
|
|
| 2014
|
The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M protein in inducing IL-6 and C3 secretion from human mesangial cells: Implications for IgA nephropathy.
Journal of Immunology.
193:317-326.
2014
|
|
| 2014
|
Enzymatic sialylation of IgA1 O-glycans: Implications for studies of IgA nephropathy.
PLoS One.
9.
2014
|
|
| 2014
|
The genetics and immunobiology of IgA nephropathy.
Journal of Clinical Investigation.
124:2325-2332.
2014
|
|
| 2014
|
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
PLoS One.
9.
2014
|
|
| 2014
|
Immune profile of IgA-dominant diffuse proliferative glomerulonephritis.
Clinical Kidney Journal.
7:479-483.
2014
|
|
| 2014
|
Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.
PLoS One.
9.
2014
|
|
| 2014
|
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Journal of Biological Chemistry.
289:5330-5339.
2014
|
|
| 2014
|
Development of animal models of human IgA nephropathy.
Drug Discovery Today: Disease Models.
11:5-11.
2014
|
|
| 2014
|
HIV-1 envelope glycan moieties modulate HIV-1 transmission.
Journal of Virology.
88:14258-14267.
2014
|
|
| 2014
|
Humoral Immune Responses to HIV in the Mucosal Secretions and Sera of HIV-Infected Women.
Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy.
71:600-607.
2014
|
|
| 2013
|
Biomarkers in IgA nephropathy: Relationship to pathogenetic hits.
Expert Opinion on Medical Diagnostics.
7:615-627.
2013
|
|
| 2013
|
Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: Role of cysteine alkylation during sample processing.
Journal of Proteomics.
92:299-312.
2013
|
|
| 2013
|
Pathogenesis of immunoglobulin A nephropathy.
Current Opinion in Nephrology and Hypertension.
22:287-294.
2013
|
|
| 2013
|
Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma.
Cellular and Molecular Life Sciences.
70:829-839.
2013
|
|
| 2013
|
Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs.
Nephrology Dialysis Transplantation.
28:320-326.
2013
|
|
| 2013
|
Pathogenesis of immunoglobulin a nephropathy: Recent insight from genetic studies.
Annual Review of Medicine.
64:339-356.
2013
|
|
| 2013
|
IgA nephropathy: Molecular mechanisms of the disease.
Annual Review of Pathology: Mechanisms of Disease.
8:217-240.
2013
|
|
| 2012
|
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
Kidney International.
82:1284-1296.
2012
|
|
| 2012
|
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy..
Clinical Nephrology.
78:465-469.
2012
|
|
| 2012
|
Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice.
Arthritis and Rheumatism.
64:4114-4124.
2012
|
|
| 2012
|
In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.
Results in Immunology.
2:166-172.
2012
|
|
| 2012
|
Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
American Journal of Pathology.
181:1338-1347.
2012
|
|
| 2012
|
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.
Kidney International.
82:790-796.
2012
|
|
| 2012
|
Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy.
International Journal of Nephrology.
2012.
2012
|
|
| 2012
|
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
Journal of the American Society of Nephrology.
23:1579-1587.
2012
|
|
| 2012
|
Implementation of proteomic biomarkers: Making it work.
European Journal of Clinical Investigation.
42:1027-1036.
2012
|
|
| 2012
|
Development of a model of early-onset IgA nephropathy.
Journal of the American Society of Nephrology.
23:1364-1374.
2012
|
|
| 2012
|
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.
PLoS Genetics.
8.
2012
|
|
| 2012
|
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
2012
|
|
| 2012
|
Induction of IgA deposits and glomerulonephritis by IgA rheumatoid factor.
Journal of the American Society of Nephrology.
23:371-373.
2012
|
|
| 2012
|
Naturally occurring structural isomers in serum IgA1 O -glycosylation.
Journal of Proteome Research.
11:692-702.
2012
|
|
| 2012
|
Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells.
Protein Expression and Purification.
81:175-180.
2012
|
|
| 2012
|
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.
Clinical Nephrology.
78:465-469.
2012
|
|
| 2012
|
Erratum: Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy (Journal of Clinical Investigation (2011) 121, 10 (3991-4002) DOI: 10.1172/JCI45563).
Journal of Clinical Investigation.
122:778.
2012
|
|
| 2011
|
Membrane-assisted online renaturation for automated microfluidic lectin blotting.
Journal of the American Chemical Society.
133:19610-19613.
2011
|
|
| 2011
|
Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis.
Kidney International.
80:1252-1254.
2011
|
|
| 2011
|
Current view of the pathogenesis of IgA nephropathy and possibilities for causal therapy.
Alergie -Praha-.
13:268-274.
2011
|
|
| 2011
|
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Journal of the American Society of Nephrology.
22:1991-1996.
2011
|
|
| 2011
|
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
Nephrology Dialysis Transplantation.
26:3451-3457.
2011
|
|
| 2011
|
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy.
Journal of Clinical Investigation.
121:3991-4002.
2011
|
|
| 2011
|
The pathophysiology of IgA nephropathy.
Journal of the American Society of Nephrology.
22:1795-1803.
2011
|
|
| 2011
|
Aberrant glycosylation of iga1 and anti-glycan antibodies in iga nephropathy: Role of mucosal immune system.
Advances in oto-rhino-laryngology.
72:60-63.
2011
|
|
| 2011
|
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Clinical Journal of the American Society of Nephrology.
6:1903-1911.
2011
|
|
| 2011
|
Reevaluation of the mucosa-bone marrow Axis in IgA nephropathy with animal models.
Advances in oto-rhino-laryngology.
72:64-67.
2011
|
|
| 2011
|
Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.
Infection and Immunity.
79:2440-2450.
2011
|
|
| 2011
|
Galactosylation of serum IgA1 O-glycans in celiac disease.
Journal of Clinical Immunology.
31:74-79.
2011
|
|
| 2011
|
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
Nature Genetics.
43:321-329.
2011
|
|
| 2011
|
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.
Kidney International.
80:79-87.
2011
|
|
| 2010
|
Clustered O-glycans of IgA1: Defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
Molecular and Cellular Proteomics.
9:2545-2557.
2010
|
|
| 2010
|
Galactose-deficient IgA1 in African Americans with IgA nephropathy: Serum levels and heritability.
Clinical Journal of the American Society of Nephrology.
5:2069-2074.
2010
|
|
| 2010
|
Genetic studies of IgA nephropathy: Past, present, and future.
Pediatric Nephrology.
25:2257-2268.
2010
|
|
| 2010
|
Recommendations for biomarker identification and qualification in clinical proteomics.
Science Translational Medicine.
2.
2010
|
|
| 2010
|
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: A comparative binding study..
Biochemistry.
49:5671-5682.
2010
|
|
| 2010
|
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.
Journal of Biological Chemistry.
285:20860-20869.
2010
|
|
| 2010
|
Involvement of envelope-glycoprotein glycans in HIV-1 biology and infection.
Archivum Immunologiae et Therapiae Experimentalis.
58:191-208.
2010
|
|
| 2010
|
Antibody-mediated protection and the mucosal immune system of the genital tract: Relevance to vaccine design.
Journal of Reproductive Immunology.
85:81-85.
2010
|
|
| 2010
|
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.
Nephrology Dialysis Transplantation.
25:1708-1713.
2010
|
|
| 2010
|
Tissue distribution and biological activities of immune complexes are determined by their size and composition.
Nephrology Dialysis Transplantation.
25:1007.
2010
|
|
| 2010
|
Comparison of methods for profiling O-glycosylation: Human proteome organisation human disease glycomics/proteome initiative multi-institutional study of IgA1.
Molecular and Cellular Proteomics.
9:719-727.
2010
|
|
| 2010
|
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis
2010
|
|
| 2010
|
Erratum: Pathogenesis of Henoch-Schönlein purpura nephritis (Pediatric Nephrology DOI: 10.1007/s00467/009-1230-x).
Pediatric Nephrology.
25:179.
2010
|
|
| 2010
|
Familial IgA nephropathy in southeastern Kentucky.
Clinical Nephrology.
73:115-121.
2010
|
|
| 2010
|
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
Molecular and Cellular Proteomics.
9:2424-2437.
2010
|
|
| 2010
|
Pathogenesis of Henoch-Schönlein purpura nephritis.
Pediatric Nephrology.
25:19-26.
2010
|
|
| 2009
|
Application of proteomic analysis to renal disease in the clinic
2009
|
|
| 2009
|
Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease
2009
|
|
| 2009
|
Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans.
Biochemistry.
48:8312-8321.
2009
|
|
| 2009
|
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments.
Mass Spectrometry Reviews.
28:703-724.
2009
|
|
| 2009
|
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Journal of Clinical Investigation.
119:1668-1677.
2009
|
|
| 2008
|
Toll-like receptor 9 affects severity of IgA nephropathy.
Journal of the American Society of Nephrology.
19:2384-2395.
2008
|
|
| 2008
|
Analysis of IgA1 N-glycosylation and its contribution to FcαRI binding.
Biochemistry.
47:11285-11299.
2008
|
|
| 2008
|
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
2008
|
|
| 2008
|
Urinary proteomics in diabetes and CKD.
Journal of the American Society of Nephrology.
19:1283-1290.
2008
|
|
| 2008
|
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.
Journal of the American Society of Nephrology.
19:1008-1014.
2008
|
|
| 2008
|
Treatment of IgA nephropathy.
Vnitrni lekarstvi.
54:239-244.
2008
|
|
| 2008
|
Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses.
Vaccine.
26:1541-1551.
2008
|
|
| 2008
|
Elucidation of the antimicrobial mechanism of mutacin 1140.
Biochemistry.
47:3308-3314.
2008
|
|
| 2008
|
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Journal of Clinical Investigation.
118:629-639.
2008
|
|
| 2008
|
Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of iga nephropathy.
Kidney and Blood Pressure Research.
31:29-37.
2008
|
|
| 2008
|
IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy.
Seminars in Nephrology.
28:78-87.
2008
|
|
| 2008
|
Overexpression of innate immune response genes in a model of recessive polycystic kidney disease.
Kidney International.
73:63-76.
2008
|
|
| 2008
|
Response to 'Overexpression of complement-component genes in Han:SPRD rats a model of polycystic kidney disease'.
Kidney International.
73:1325.
2008
|
|
| 2007
|
Body fluid proteomics for biomarker discovery: Lessons from the past hold the key to success in the future.
Journal of Proteome Research.
6:4549-4555.
2007
|
|
| 2007
|
Electrophoretic methods for analysis of urinary polypeptides in lgA-associated renal diseases.
Electrophoresis.
28:4469-4483.
2007
|
|
| 2007
|
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.
Pediatric Nephrology.
22:2067-2072.
2007
|
|
| 2007
|
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: Implications for IgA nephropathy.
Analytical and Bioanalytical Chemistry.
389:1397-1407.
2007
|
|
| 2007
|
Isolation of flagellated bacteria implicated in Crohn's disease.
Inflammatory Bowel Diseases.
13:1191-1201.
2007
|
|
| 2007
|
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.
World Journal of Urology.
25:467-476.
2007
|
|
| 2007
|
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine
2007
|
|
| 2007
|
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Kidney International.
71:1148-1154.
2007
|
|
| 2007
|
The genetics of IgA nephropathy.
Nature Reviews Nephrology.
3:325-338.
2007
|
|
| 2007
|
IgA nephropathy and henoch-schoenlein purpura nephritis: Aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Contributions to Nephrology.
157:134-138.
2007
|
|
| 2007
|
IgA nephropathy: A clinical overview.
Contributions to Nephrology.
157:19-26.
2007
|
|
| 2007
|
IgA nephropathy: Characterization of IgG antibodies specific for galactose-deficient IgA1.
Contributions to Nephrology.
157:129-133.
2007
|
|
| 2007
|
IgA nephropathy: Current views of immune complex formation.
Contributions to Nephrology.
157:56-63.
2007
|
|
| 2007
|
Identification and Characterization of CMP-NeuAc:GalNAc-IgA1 α2,6-Sialyltransferase in IgA1-producing Cells.
Journal of Molecular Biology.
369:69-78.
2007
|
|
| 2007
|
CE - A multifunctional application for clinical diagnosis.
Electrophoresis.
28:1407-1417.
2007
|
|
| 2007
|
Advances in urinary proteome analysis and biomarker discovery.
Journal of the American Society of Nephrology.
18:1057-1071.
2007
|
|
| 2007
|
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Molecular Immunology.
44:2598-2604.
2007
|
|
| 2007
|
Clinical proteomics: A need to define the field and to begin to set adequate standards
2007
|
|
| 2006
|
High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Proteomics.
6:5615-5627.
2006
|
|
| 2006
|
IgA-containing immune complexes in the urine of IgA nephropathy patients.
Nephrology Dialysis Transplantation.
21:2478-2484.
2006
|
|
| 2006
|
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation.
Electrophoresis.
27:2111-2125.
2006
|
|
| 2006
|
Immunoglobulin A and renal diseases.
Vnitrni lekarstvi.
52:256-262.
2006
|
|
| 2005
|
Urinary IgA in IgA nephropathy patients - A new finding which support diagnosis of IgA nephropathy.
Aktuality V Nefrologii.
11:11-17.
2005
|
|
| 2005
|
Heterogeneity of IgG glycosylation in adult periodontal disease
2005
|
|
| 2005
|
Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry.
Journal of Biological Chemistry.
280:19136-19145.
2005
|
|
| 2005
|
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals.
AIDS.
19:381-389.
2005
|
|
| 2005
|
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Kidney International.
67:504-513.
2005
|
|
| 2004
|
Glycosylation and Size of IgA1 Are Essential for Interaction with Mesangial Transferrin Receptor in IgA Nephropathy.
Journal of the American Society of Nephrology.
15:622-634.
2004
|
|
| 2004
|
IgA nephropathy: An update.
Current Opinion in Nephrology and Hypertension.
13:171-179.
2004
|
|
| 2003
|
Structure and dynamics of the lantibiotic mutacin 1140.
Biochemistry.
42:10372-10384.
2003
|
|
| 2002
|
The Fap1 fimbrial adhesin is a glycoprotein: Antibodies specific for the glycan moiety block the adhesion of Streptococcus parasanguis in an in vitro tooth model.
Molecular Microbiology.
43:147-157.
2002
|
|
| 2002
|
IgA nephropathy pathogenetic importance of immunoglobulin a glycosylation and clinical presentation.
Casopis lekaru ceskych.
141:729-734.
2002
|
|
| 2002
|
Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Kidney International.
62:465-475.
2002
|
|
| 2001
|
Progress in molecular and genetic studies of IgA nephropathy.
Journal of Clinical Immunology.
21:310-327.
2001
|
|
| 2001
|
Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II.
FEMS Microbiology Letters.
195:139-144.
2001
|
|
| 2001
|
Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II..
FEMS Microbiology Letters.
195:139-144.
2001
|
|
| 2000
|
Heterogeneity of O-glycosylation in the hinge region of human IgA1.
Molecular Immunology.
37:1047-1056.
2000
|
|
| 2000
|
Expression of the recombinant human immunoglobulin J chain in Escherichia coli.
Molecular Immunology.
37:133-140.
2000
|
|
| 2000
|
Biochemical structural analysis of the lantibiotic mutacin II.
Journal of Biological Chemistry.
275:15845-15850.
2000
|
|
| 2000
|
Production, distribution, and structure of human IgA molecules.
Nihon Jinzo Gakkai shi.
42.
2000
|
|
| 2000
|
Detection of antimicrobials in bee products with activity against viridans streptococci.
Journal of Alternative and Complementary Medicine.
6:383-389.
2000
|
|
| 2000
|
IgA1 glycosylation and the pathogenesis of IgA nephropathy.
American Journal of Kidney Diseases.
35:551-554.
2000
|
|
| 2000
|
Invited Lecture 3:Production, distribution, and structure of human IgA molecules.
Nihon Jinzo Gakkai shi.
42:133-133.
2000
|
|
| 1999
|
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Journal of Clinical Investigation.
104:73-81.
1999
|
|
| 1999
|
Progress in the pathogenesis of IgA nephropathy..
Advances in nephrology from the Necker Hospital.
29:53-72.
1999
|
|
| 1999
|
The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc.
Applied and Environmental Microbiology.
65:1356-1360.
1999
|
|
| 1998
|
Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans.
Gene.
206:37-43.
1998
|
|
| 1998
|
Diacylglycerol kinase is involved in regulation of expression of the lantibiotic mutacin II of Streptococcus mutans.
Journal of Bacteriology.
180:167-170.
1998
|
|
| 1998
|
Extraction, assay, and analysis of antimicrobials from plants with activity against dental pathogens (Streptococcus sp.).
Journal of Alternative and Complementary Medicine.
4:39-45.
1998
|
|
| 1998
|
Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans.
Infection and Immunity.
66:2743-2749.
1998
|
|
| 1998
|
Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy.
Applied and Environmental Microbiology.
64:2335-2340.
1998
|
|
| 1997
|
Expression and protein engineering of the lantibiotic mutacin II
1997
|
|
| 1997
|
Structure and activity of the lantibiotic mutacin II. Evidence for two domains?
1997
|
|
| 1997
|
Microbially-produced peptides having potential application to the prevention of dental caries.
International Journal of Antimicrobial Agents.
9:95-105.
1997
|
|
| 1997
|
Nitrogen source regulates expression of alanine dehydrogenase isoenzymes in Streptomyces avermitilis in a chemically defined medium.
Canadian Journal of Microbiology.
43:189-193.
1997
|
|
| 1997
|
Ribosomal RNA (rrn) operons in Streptococcus mutans and nucleotide sequence of tRNA(Pro) gene associated with rrnB.
Molecular Oral Microbiology.
12:227-230.
1997
|
|
| 1997
|
Transposon mutagenesis: Cloning of chromosomal DNA from the site of Tn916 insertion using polymerase chain reaction
1997
|
|
| 1996
|
Detection of modified amino acids in lantibiotic peptide mutacin II by chemical derivatization and electrospray ionization-mass spectroscopic analysis.
Analytical Biochemistry.
236:358-360.
1996
|
|
| 1996
|
Characterization of PepB, a group B streptococcal oligopeptidase.
Infection and Immunity.
64:3401-3406.
1996
|
|
| 1996
|
Programmed cell death [3].
Science.
274:20-21.
1996
|
|
| 1995
|
Mutacin II, a bactericidal lantibiotic from Streptococcus mutans.
Antimicrobial Agents and Chemotherapy.
39:2656-2660.
1995
|
|
| 1994
|
Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans.
Journal of Bacteriology.
176:4316-4320.
1994
|
|
| 1993
|
Production of avermectin A2a and monoglycosides A2a and B2a by a strain of Streptomyces avermitilis.
Folia Microbiologica.
38:367-370.
1993
|
|
| 1993
|
Instability of the production of avermectins, sporulation, and pigmentation in Streptomyces avermitilis.
Canadian Journal of Microbiology.
39:265-267.
1993
|
|
| 1992
|
N-Acetyl-isoleucine in Streptomyces avermitilis.
FEMS Microbiology Letters.
94:85-87.
1992
|
|
| 1992
|
Screening for a new generation of anthelminthic compounds. In vitro selection of the nematode Caenorhabditis elegans for ivermectin resistance.
Folia Microbiologica.
37:237-238.
1992
|
|
| 1992
|
Nitrogen regulation of fatty acids and avermectins biosynthesis in Streptomyces avermitilis.
FEMS Microbiology Letters.
93:57-61.
1992
|
|
| 1992
|
Enzymes of ammonium assimilation in Streptomyces avermitilis.
Folia Microbiologica.
37:261-266.
1992
|
|
| 1991
|
Isolation of erythromycin A N-oxide and pseudoerythromycin A hemiketal from fermentation broth of Saccharopolyspora erythraea by thin-layer and high-performance liquid chromatography.
Journal of Chromatography A.
558:265-272.
1991
|
|
| 1990
|
Biosynthesis of avermectins and lipids in Streptomyces avermitilis.
FEMS Microbiology Letters.
70:291-294.
1990
|
|
| 1988
|
A rapid screening of Streptomycesavermitilis production strains
1988
|
|
| 1988
|
Nitrogen regulation of avermectins biosynthesis in Streptomyces avermitilis in a chemically defined medium
1988
|
|
